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Abstract
Background: Both genetic and environmental factors contribute to human diseases. Most
common diseases are influenced by a large number of genetic and environmental factors, most of
which individually have only a modest effect on the disease. Though genetic contributions are
relatively well characterized for some monogenetic diseases, there has been no effort at curating
the extensive list of environmental etiological factors.
Results: From a comprehensive search of the MeSH annotation of MEDLINE articles, we identified
3,342 environmental etiological factors associated with 3,159 diseases. We also identified 1,100
genes associated with 1,034 complex diseases from the NIH Genetic Association Database (GAD),
a database of genetic association studies. 863 diseases have both genetic and environmental
etiological factors available. Integrating genetic and environmental factors results in the "etiome",
which we define as the comprehensive compendium of disease etiology. Clustering of
environmental factors may alert clinicians of the risks of added exposures, or synergy in
interventions to alter these factors. Clustering of both genetic and environmental etiological factors
puts genes in the context of environment in a quantitative manner.
Conclusion: In this paper, we obtained a comprehensive list of associations between disease and
environmental factors using MeSH annotation of MEDLINE articles. It serves as a summary of
current knowledge between etiological factors and diseases. By combining the environmental
etiological factors and genetic factors from GAD, we computed the "etiome" profile for 863
diseases. Comparing diseases across these profiles may have utility for clinical medicine, basic
science research, and population-based science.
Background
Etiologies of human diseases include both genetic and
non-genetic (here considered as "environmental" in the
broadest sense) factors, such as behaviors and chemical
exposures. Here, we are defining disease broadly, includ-
ing syndromes, accidents, and conditions. An example of
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genetic factors is cystic fibrosis, an autosomal recessive
disease from a mutation in the cystic fibrosis transmem-
brane conductance regulator (CFTR). On the other end of
the spectrum, mesothelioma is a disease that is almost
always a result of previous exposure to asbestos. The vast
majority of diseases, however, are influenced by a large
number of both genetic and environmental factors. In a
recent analysis of Scandinavian twin registries, genetic fac-
tors were estimated to account for 27% of the risk factors
for breast cancer, 35% for colon cancer, and 42% for
breast cancer, with the remaining percentages due to envi-
ronmental factors [1]. In addition, genetic and environ-
mental factors almost never act independently. A classical
example is Phenylketonuria (PKU): even with the genetic
mutation, the disease can be clinically avoided by elimi-
nating phenylalanine from the diet.
Decades-long efforts to sequence the human genome have
yielded substantial tools to comprehensively survey posi-
tions of DNA variation [2]. These tools have been used to
study genome-wide association and linkage between vari-
ations and diseases successfully yielding an impressive list
of genes associated with diseases. Though most studies
focus on either a single gene, loci, or a single disease,
many databases, such as Online Mendelian Inheritance of
Men (OMIM) [3], PharmGKB [4], and the NIH Genetic
Association Database (GAD) [5], have been created to col-
lect such disease-gene associations.
The environmental contributions to diseases have also
been widely studied. Similar to genetic associations, most
studies focus on singular diseases. So far, to our knowl-
edge, there has been no comprehensive list of environ-
mental factors and their disease associations, similar to
the databases listed above. This lack of a comprehensive
list is likely due to the fact that environmental factors are
a heterogeneous group spanning many categories, and
even representing these factors is a challenge.
In this paper, we present a first-step towards the human
disease "etiome," which we define as the comprehensive
compendium of both genetic and environmental etiolog-
ical factors associated with diseases. The disease-gene
associations are obtained from the Genetic Association
Database (GAD). The disease-environmental factor asso-
ciations are obtained from a comprehensive analysis of
the MeSH (Medical Subject Heading) annotations of pub-
lished literature in the MEDLINE database. After integrat-
ing to create a single master set of genetic and
environmental etiology factors and diseases, we cluster
the etiological factors and determine how genes and envi-
ronmental factors share similar disease profiles.
Results
We first sought to identify and integrate lists of genetic
and environmental etiological factors associated with dis-
eases. Our search of the Genetic Association Database
(GAD) [5] resulted in 5,727 disease-gene associations
between 1,034 diseases and 1,100 genes. Table 1 lists the
top 10 genes with variants associated with the greatest
number of diseases. Angiotensin converting enzyme
(ACE) has been associated with more distinct diseases and
conditions than any other human gene.
Literally hundreds of thousands of articles have been pub-
lished on the environmental contributions to individual
diseases. Representing these environmental factors and
searching the literature for these articles describing dis-
ease-environmental factor relationships would be a
daunting task if it were not for Medical Subject Headings
(MeSH), a controlled vocabulary created by the National
Library of Medicine (NLM) to index journal articles and
books in the life sciences. All articles in MEDLINE have
been annotated with MeSH by NLM curators or designees.
The 2007 version of MeSH has 24,357 subject headings
organized in 16 categories including diseases, drugs and
chemicals, and anatomical terms. MeSH also uses 83
qualifiers, which can be added to subject headings to
emphasize a particular aspect of the headings. For exam-
Table 1: Top 10 genes having variants associated with the greatest number of diseases, as identified from the NIH Genetic Association 
Database.
Gene Symbol and Name Count of Distinct Associated Diseases
ACE (angiotensin I converting enzyme) 100
TNF (tumor necrosis factor alpha) 88
TP53 (tumor protein 53) 73
VDR (vitamin D receptor) 66
HLA.DRB1 59
APOE (apolipoprotein E) 56
NOS3 (nitric oxide synthase 3) 54
MTHRF (methylenetetrahydrofolate redutase) 53
HLA.DQB1 46
IL10 (interleukin 10) 46Page 2 of 10
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qualifier; Lung Neoplasms/etiology describes the subhead-
ing of articles on the etiology of lung neoplasms. Every
article in MEDLINE is indexed with 10–15 subject head-
ings, a few of which are designated as major (i.e., key
points of the article), often designated with an asterisk.
MeSH annotation of MEDLINE provides a knowledge
source that is concise and amenable to computational
approaches.
We downloaded MeSH annotations of all articles in
MEDLINE (over 4.6 million articles) that were published
between 1996 and 2006 from the MEDLINE Baseline
Repository http://mbr.nlm.nih.gov/. We examined the
definition and purpose of MeSH qualifiers as published in
the MeSH Indexing Manual (Chapter 19 of the Indexing
Manual, http://www.nlm.nih.gov/mesh/indman/
chapter_19.html) to identify qualifiers that encode etio-
logical information for diseases. We found the appropri-
ate qualifiers include chemically induced, complication,
adverse effects, toxicity, and poisoning. These qualifiers,
together with their scope note from Chapter 19 of the
Indexing Manual and sample indexing, are listed in Table
2. Only those subject heading/qualifier annotations that
are designated as major are examined. Note that the qual-
ifier complication can be used in two ways. First, the quali-
fier may annotate one disease causing another. Second,
the qualifier or the co-existence of two or more diseases
for which no causal relationship has been determined.
These two scenarios can be differentiated by whether one
of the diseases is annotated with etiology. In these cases,
our study only included articles annotated as one disease
causing another.
Our search of the MeSH annotations from the MEDLINE
database resulted in 133,781 disease-environmental fac-
tor relationships between 3,159 diseases and 3,342 envi-
ronmental factors. To capture the various categories that
these environmental factors belong to, we grouped them
based on their semantic types in the Unified Medical Lan-
Table 2: Scope and sample indexing of the MeSH qualifiers used in our study. The five MeSH qualifiers relevant to this study are listed, 
from the 83 available. Scope notes are taken from the Chapter 19 of the MeSH Indexing Manual http://www.nlm.nih.gov/mesh/indman/
chapter_19.html.
MeSH Qualifier Scope Note Example indexing
(MeSH subject Heading/qualifier)
Chemically induced (chem ind) "Used for biological phenomena, diseases, syndromes, congenital 
abnormalities, or symptoms caused by endogenous or exogenous 
substances."
Indomethacin-induced peptic ulcer:
Peptic Ulcer/chem ind
Indomethacin/adv eff
Complication
(compl)
"Used with diseases to indicate conditions that co-exist or follow, i.e., 
co-existing diseases, complications, or sequelae."
If disease A causes disease B, this will be 
indexed as
Disease A/compl
Disease B/etiol
If it is not known whether disease A 
causes disease B or disease B causes 
disease A, the article will be indexed as
Disease A/compl
Disease B/compl
Adverse Effects
(adv eff)
"Used with drugs, chemicals, or biological agents in accepted dosage – 
or with physical agents or manufactured products in normal usage – 
when intended for diagnostic, therapeutic, prophylactic, or anesthetic 
purposes. It is used also for adverse effects or complications of 
diagnostic, therapeutic, prophylactic, anesthetic, surgical, or other 
procedures, but excludes contraindications for which 
"contraindications" is used."
Hepatotoxicity of acetaminophen given 
for fever:
Acetaminophen/adv eff/ther use
Liver Diseases/chem ind
Fever/drug ther
Toxicity
(tox)
"Used with drugs and chemicals for experimental human and animal 
studies of their ill effects. It includes studies to determine the margin 
of safety or the reactions accompanying administration at various 
dose levels. It is used also for exposure to environmental agents. 
Poisoning should be considered for life-threatening exposure to 
environmental agents."
Cocaine induced cardiomyopathies:
Cocaine/tox
Cardiomyopathies/chem ind
Poisoning
(pois)
"Used with drugs, chemicals, and industrial materials for human or 
animal poisoning, acute or chronic, whether the poisoning is 
accidental, occupational, suicidal, by medication error, or by 
environmental exposure."
Acidosis due to ethylene glycol poisoning:
Acidosis/chem. ind
Ethylene Glycol/poisPage 3 of 10
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to 78 distinct semantic types. Table 3 lists the top 10
semantic types of the environmental factors and the
number of factors belonging to each type. The top cate-
gory is Disease or Syndrome, reflecting disease progression
or complications of a disease. An example of this is the
disease diabetes leading to the disease diabetic neuropathy.
Beyond this, thousands of drugs and chemicals have been
linked etiologically to disease. Table 4 lists the ten etiolog-
ical factors that are involved in the greatest number of dis-
eases.
Even the top ten factors span a number of semantic types.
The role of Systemic Lupus Erythematosus (SLE) and HIV
in leading to successive conditions is well known. The
incidence of HIV infection in the population is at least an
order of magnitude higher than the incidence of SLE; that
both of these make up the top two factors suggests that
our relations are not necessarily biased by incidence. Most
of the top ten etiological factors are medical procedures
themselves, and may reflect the continual shift of disease
management from acute and semi-acute management of
a life-threatening condition to the chronic management
of subsequent complications. Smoking is the only human
behavior listed in the top ten.
The disease-environmental relationship with the greatest
number of articles is heparin with thrombocytopenia (508
articles). Other associations with over 300 articles include
carcinogens with neoplasms, environmental exposure with
occupational disease, and hormone replacement therapy with
breast neoplasms.
The human disease "etiome"
After integrating relationships extracted from GAD and
MEDLINE, we found 863 diseases have associations with
both genetic and environmental factors. Combining both
types of etiological factors for these diseases resulted in
69,223 associations between 863 diseases and 4173 etio-
logical factors.
We clustered all the etiological factors (both genetic and
environmental) based on similarities of their disease asso-
ciations (Figure 1; for details, see Methods). The strongest
pairings of environmental factors include some pairings
that could be considered "is a" relationships, such as Par-
kinsonian Disorders with Neurodegenerative Diseases, Sun-
light with Nonionizing Radiation, and Tissue Transplantation
with Organ Transplantation, as well as many non-"is a"
relationships, like Anterior Uveitis with Mouth Diseases,
Mental Retardation with Chromosome Disorders, and Plati-
num Compounds with Chlorine Compounds.
Overall, etiological factors affecting the same organ sys-
tems tend to cluster together. One example is a cluster that
has diabetes mellitus type 1, diabetes type 2, and hyperg-
lycemia (Figure 2). As diseases, type 1 and type 2 diabetes
have distinctly different etiology. Type 1 diabetes results
from the destruction of beta cells within the islets in the
pancreas, whereas type 2 diabetes results from initial insu-
lin resistance. However, they lead to the same set of com-
plications including accelerated atherosclerosis,
neuropathy, retinopathy, nephropathy, and infections. It
is this shared profile of complications that makes diabetes
type 1 and type 2 cluster next to each other. This example
also illustrates how diseases can also be etiological factors
for other diseases. Other examples (data not shown)
Table 4: Top ten etiological factors involved with the greatest number of diseases
Type of Etiological Factors Count of Distinct Associated Diseases
HIV infections 203
Lupus Erythematosus, Systemic 181
Smoking 171
Antineoplastic Agents 167
Bone Marrow Transplantation 158
Immunosuppressive Agents 156
Renal Dialysis 154
Kidney Transplantation 151
Antineoplastic Combined Chemotherapy Protocols 138
Acquired Immunodeficiency Syndrome 128
Table 3: Top 10 semantic types of the environmental factors 
causing disease, as represented in the Unified Medical Language 
System (UMLS).
Semantic Type of Environmental Factors Count
Disease or Syndrome 1932
Pharmacologic Substance 1250
Organic Chemical 1076
Therapeutic or Preventive Procedure 521
Neoplastic Process 424
Amino Acid, Peptide, or Protein 310
Biologically Active Substance 274
Hazardous or Poisonous Substance 251
Congenital Abnormality 160
Injury or Poisoning 150Page 4 of 10
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Clustering of genetic and environmental factors together, based on similarity of profiles of diseases for which they are etiolog-icalFigure 1
Clustering of genetic and environmental factors together, based on similarity of profiles of diseases for which 
they are etiological. Only the top 427 etiological factors based on counts of articles are shown arbitrarily, for visibility. 
Arrows indicate the position of genes across this clustering, showing that genes do not all cluster together. Numbers and let-
ters on the left indicate regions magnified for subsequent figures. Please see the journal's website or our website http://eti-
ome.stanford.edu for a PDF version of this figure that can be magnified.
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BMC Bioinformatics 2009, 10(Suppl 2):S14 http://www.biomedcentral.com/1471-2105/10/S2/S14include a cluster of anticoagulants such as heparin and
Coumadin, a cluster of infections from CMV, RSV, gram
negative bacteria, and streptococcus, and a cluster that
suppress the immune system such as heart transplanta-
tion, lung transplantation, and immunosuppression.
However, some associations are not so obvious. For exam-
ple, sleep apnea, calcinosis, and inborn errors of metabo-
lism are also part of the cluster that has diabetes,
hyperglycemia, and hyperlipidemia (Figure 2). Close
examination of this cluster shows three pathophysiologi-
cal processes underway. Diabetes is well known to lead to
increased atherosclerosis. Inborn errors of metabolism
can lead to impaired energy metabolism and storage.
Sleep apnea has been associated with increased oxidative-
stress and pulmonary hypertension. But all three seem-
ingly separate processes lead to cardiovascular sequelea
such as cerebrovascular accident and myocardial infarc-
tion [6-9]. The similarity of these etiologies in leading to
nervous system sequelae and postoperative complications
also contributed to the clustering. This result suggests that
patients with both sleep apnea and diabetes mellitus may
be at higher risk for cardiovascular mortality and morbid-
ity. Even though the epidemiology of sleep apnea and dia-
betes interact [10], studies have shown that the
cardiovascular morbidity and mortality remain in patient
with sleep apnea even after adjusting for diabetes [9].
We also examined the location of the genetic factors in the
"etiome", focusing on those five genes that were associ-
ated with the 863 diseases with the highest article counts:
TP53, CTL4, TNF, ACE, and NOS3. While these five genes
were scattered across our clustering of the "etiome", sur-
prisingly, they fell into three distinct areas of the "etiome":
oncogenesis, inflammation and immunity, and metabo-
lism.
Not surprisingly, TP53 was clustered with various other
carcinogens such as radon, tobacco, electromagnetic
fields, pesticides, environmental pollutants, and chlorin-
ated hydrocarbons (Figure 3A). This reflects the role of
TP53 as "the guardian of the genome" in the face of car-
cinogens, and specifically reflects the morbidity caused
from TP53 variants or loss of functioning of this impor-
tant tumor-suppressor gene.
In another region of the clustered "etiome", CTLA4 (cyto-
toxic T-lymphocyte antigen 4) and TNF were clustered
with immune-mediated processes such as thyroiditis, viral
hepatitis vaccines, and immunizations, and more distant
similarity with a myriad of environmental pollutants,
such as toluenes, air pollution, polymers, and even sili-
cones (Figure 3B). These two genes share associations
with 15 different diseases, including rheumatoid arthritis,
asthma, celiac disease, ulcerative colitis, Crohn's Disease,
Graves Disease, and multiple sclerosis.
ACE and NOS3 are associated with inflammation, hyper-
insulinism, and metabolic diseases (Figure 3C). ACE and
NOS3 are best known for their role in blood pressure reg-
ulation, but both are associated with 28 different diseases,
including Alzheimer Disease, unstable angina, brain
ischemia, coronary disease, systemic lupus erythemato-
sus, preeclampsia, and autosomal dominant polycystic
kidney disease. ACE has recently also been implicated in
glucose control [11]. Directly neighboring this pair of
genes is APOE, which is interestingly partnered with peri-
odontal disease. While much has been written about the
role of APOE in Alzheimer Disease, the overall profile of
APOE across diseases places it as being similar to perio-
dontal disease. Both APOE and periodontal disease are
known etiologies or complicating factors for arteriosclero-
sis and its manifestations. Curiously, periodontal disease
has been suggested as a risk factor for the development of
Alzheimer Disease, but only in a single study [12].
The diabetes clusterFigure 2
The diabetes cluster. As etiological factors, type 1 diabetes mellitus and type 2 diabetes mellitus share similar disease pro-
files with calcinosis, hyperlipidemia, sleep apnea, and inborn errors of metabolism. Branches are shown shorter here and in Fig-
ure 3 as compared to Figure 1, to improve readability of text. The branching patterns and relative lengths of branches are 
identical to Figure 1.
Hyperglycemia
Anoxia
Sleep Apnea Syndromes
Sleep Apnea  Obstructive
Amino Acid Metabolism  Inborn Errors
Brain Diseases  Metabolic  Inborn
Diabetes Complications
Diabetes Mellitus  Type 1
Diabetes Mellitus  Type 2
Calcinosis
HyperlipidemiaPage 6 of 10
(page number not for citation purposes)
BMC Bioinformatics 2009, 10(Suppl 2):S14 http://www.biomedcentral.com/1471-2105/10/S2/S14Discussion
We have integrated publicly available gene-disease and
environment-disease relations to build a first pass survey
of the "etiome", or a comprehensive profile of disease eti-
ologies, across 863 diseases.
In the past, efforts have been focused on identifying and
characterizing the genetic influences on diseases.
Recently, a "diseasome" was generated using the Online
Mendelian Inheritance in Man (OMIM) database [13].
However, no environmental factors were included in that
study, and even more concerning, most of the diseases in
OMIM are monogenic diseases that follow Mendelian
inheritance. Because of this, many commonly occurring
complex polygenic diseases or disorders were not
included in that study. This is one of the reasons why we
used the NIH Genetic Association Database (GAD) as our
primary source of genetic associations, instead of OMIM.
A second reason we used GAD is that diseases are already
represented by MeSH, which facilitated integration of
genetic and environmental etiologies for the same dis-
eases.
To our knowledge, our effort is the first towards building
an automated system to collect a comprehensive list of all
environmental influences on diseases. We identified 3342
Sample clustering of genetic and environmental factorsFigur  3
Sample clustering of genetic and environmental factors. Branches indicated in Figure 1 are shown in more detail here. 
A. Variants in TP53 lead to a set of diseases closely similar to the diseases caused by radon, tobacco, as well as other carcino-
gens and pollutants. B. CTLA4 (cytotoxic T-lymphocyte antigen 4) and TNF were clustered with immune-mediated processes 
such as thyroiditis, viral hepatitis vaccines, and immunizations, and more distant similarity with a myriad of environmental pol-
lutants. C. Variants in APOE lead to the same diseases as periodontal disease, while ACE and NOS3 share profiles with inflamma-
tion. These three genes cluster with metabolic diseases and hyperinsulinism, as etiological factors for other diseases.
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search of human-curated publication annotations from
MEDLINE. Combined with the genetic influences, our
"etiome" can contribute to our understanding towards
genetic and environmental contribution to diseases.
In addition, clustering of genetic and environmental fac-
tors together based on their disease profile puts genes in
their environmental context, and may even suggest gene-
environment interactions. This is reflected in our results
with TP53, CTLA4, TNF, ACE and NOS3. This may
become another way to explore gene function, as well as
to suggest possible environmental interventions for
genetic diseases. While we clustered genes and environ-
mental factors based on the similarities in the diseases
they are associated with, careful examination of the subtle
differences in these profiles may also indicate gene-dis-
ease and environmental-disease relations that are "miss-
ing" and might make targeted hypotheses for validation.
We acknowledge that our modeling of gene-environment
interactions here is simple and serves only as a first step.
Several of the genes we find as having disease-profiles sim-
ilar to environmental etiologies only express their associ-
ation under specific environmental conditions. Though
we are considering genes and environmental factors as
separate when clustered, we realize that in the majority of
cases, these factors work together to yield a disease. We
also acknowledge that the assignment of genetic associa-
tions to genes can operate in a biased manner, in that
when one disease is associated with a gene, many investi-
gators may then try to associate other related diseases to
that gene.
The distinction between genetic and environmental fac-
tors is somewhat arbitrary. We define environmental etio-
logical factors as non-genetic factors that have been
associated with the disease from an "etiological" point of
view in MEDLINE. As a result, diseases that are predispos-
ing factors to other diseases are included. In reality, many
of the disease predispositions themselves could be due to
genetic factors. For example, polymorphisms in APOA4
have been associated with the risk of myocardial infarc-
tion in patients with obesity and type 2 diabetes [14].
These ternary and quaternary relations (i.e. one gene,
APOA4, and two conditions, obesity and type 2 diabetes,
leading to another condition, myocardial infarction) are
highly interesting to study, but we acknowledge will be
missed by our current approach.
We acknowledge several limitations in the use of MeSH to
represent etiological factors. There is variable depth of
coverage of scientific areas in MeSH, and while NLM cura-
tors may attempt to use the most specific terms for anno-
tate a paper, we acknowledge there may be variable depth
of term usage. There may also be a lack of discrimination
between environmental factors at different times in the
etiologic cascade. This is reflected by the trivial "is a" pair-
ings seen in our clustering. MeSH itself is a dynamically
changing structure, with newer terms introduced yearly.
Another source of our "is a" pairings might be that certain
terms may not have been available for annotation for
older publications, and thus these publications may not
have been identified with the most specific term currently
available.
Our list is nearly comprehensive, but not technically com-
plete. We acknowledge that this first step does not include
microorganisms that cause infectious diseases. This is
because the MeSH qualifier microbiology "permits its use
with disease headings for discussions of microbes in a dis-
ease whether the microbe is the causative agent or not."
http://www.nlm.nih.gov/mesh/indman/chapter_19.html
The same is true for virology and parasitology. To be con-
servative, we decided not to include these qualifiers in our
study to avoid false positive relationships. Infectious dis-
eases and their causative organisms are relatively well
characterized. In the future, we plan to look for other
sources of information to better delineate the association
between infectious agents and the diseases they cause. In
addition, we acknowledge that while the NIH Genetic
Association Database is human curated, it may be missing
gene-disease relationships.
We also acknowledge that we cannot distinguish positive
and negative findings solely by using MeSH annotations.
For example, a publication showing that the use of hor-
mone replacement therapy has no effect on breast cancer
incidence has the same MeSH annotations as a publica-
tion showing that hormone replacement therapy is statis-
tically associated with increasing breast cancer incidence.
Distinguishing positive from negative findings will likely
require natural language processing of the title and
abstracts of these publications, or using other curated
sources such as the Cochrane collection. Our criteria for
inclusion in this study is minimally filtered, in that if any
publication exists linking etiology with disease, we con-
sider that link as a positive association. Given the known
biases in publication acceptance, it is probably rare that a
negative finding is published without a preceding positive
and opposite finding, so we feel that potential inclusion
of these negative studies is justified given that there was
likely a positive study to precede them. However, this
assumption is unverified.
We acknowledge that we are missing actual odds ratio, rel-
ative risk or penetrance of these etiological factors and
their associated disease. To our knowledge, we are una-
ware of any repositories with this type of quantifiable
data, but we also submit that any quantifiable odds ratiosPage 8 of 10
(page number not for citation purposes)
BMC Bioinformatics 2009, 10(Suppl 2):S14 http://www.biomedcentral.com/1471-2105/10/S2/S14are likely to be a factor of the experimental design and
conditions of a particular study, which are currently
ignored in our work.
Our future work will include refining our collection of eti-
ological factors, clustering the diseases as reflected by our
"etiome", and building graphical networks between
genes, environmental factors, and diseases. The clustering
of iatrogenic and health-care related sources of disease
with genetic factors is of particular interest to us, as this
suggests that two disparate fields of research, quality of
care improvement and genetic associations, could be used
together to jointly model the incidence of disease. This is
of prime importance given the current high estimates for
the role of medical errors in mortality and morbidity.
In addition, most of our primary sources of relations have
an implicit temporality, in terms of when each relation
was discovered or published. We envision retrospective
time-series studies of changes to determine how our
dynamic view of the role of genetics and environment on
disease can be demonstrated through changes in the clus-
tering of the "etiome."
Conclusion
In this paper, we obtained a comprehensive set of associ-
ations between disease and etiological factors from the
NIH Genetic Association Database and MeSH annota-
tions of MEDLINE articles. We computed the profiles
across the "etiome" for 863 diseases, and clustered these
etiological factors. This is just a first-step towards the auto-
mated analysis of gene-environmental relationships
across diseases. Our work may have value for both clinical
medicine and basic science research: clustering of environ-
mental factors may alert clinicians of the risks of added
exposure and clustering of genetic and environmental eti-
ological factors may reveal novel gene functions and dys-
functions.
Methods
Identifying disease-gene associations
The Genetic Association Database (GAD) is a curated
archive of human genetic association studies supported
by the US National Institutes of Health [5]. The October
2006 version of GAD was downloaded from http://genet
icassociationdb.nih.gov/. Only positive genetic associa-
tions were selected; relations indicating negative findings
were removed. Relations in GAD link NCBI Entrez Gene
identifiers to diseases as represented by MeSH terms. Each
separate article noting a relationship between a gene and
disease is initially counted separately, so that article
counts are maintained.
Clustering of etiological factors
Associations between diseases and genes, or diseases and
environmental factors are represented as binary values in
a table with diseases as rows and gene/environmental fac-
tors as columns. Hierarchical clustering is performed on
etiological factors using binary distance and complete
agglomeration method. Computations were performed
using R [15]. In order for the dendrogram to be easily vis-
ualized, only those etiological factors associated with the
highest article counts are clustered.
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